All Relations between Muscle Weakness and dmd

Publication Sentence Publish Date Extraction Date Species
Craig M Zaidman, Natalie L Goedeker, Amal A Aqul, Russell J Butterfield, Anne M Connolly, Ronald G Crystal, Kara E Godwin, Kan N Hor, Katherine D Mathews, Crystal M Proud, Elizabeth Kula Smyth, Aravindhan Veerapandiyan, Paul B Watkins, Jerry R Mendel. Management of Select Adverse Events Following Delandistrogene Moxeparvovec Gene Therapy for Patients With Duchenne Muscular Dystrophy. Journal of neuromuscular diseases. 2024-04-12. PMID:38607761. individuals living with dmd exhibit progressive muscle weakness resulting in loss of ambulation and limb function, respiratory insufficiency, and cardiomyopathy, with multiorgan involvement. 2024-04-12 2024-04-15 Not clear
Akiko Wakisaka, Koichi Kimura, Hiroyuki Morita, Koki Nakanishi, Masao Daimon, Masanori Nojima, Hideki Itoh, Atsuhito Takeda, Ruriko Kitao, Tomihiro Imai, Tetsuhiko Ikeda, Takashi Nakajima, Chigusa Watanabe, Toshihiro Furukawa, Ichiro Ohno, Chiho Ishida, Norihiko Takeda, Kiyonobu Koma. Efficacy and Tolerability of Ivabradine for Cardiomyopathy in Patients with Duchenne Muscular Dystrophy. International heart journal. vol 65. issue 2. 2024-03-31. PMID:38556332. patients with dmd suffer from progressive muscle weakness, inevitable cardiomyopathy, increased heart rate (hr), and decreased blood pressure (bp). 2024-03-31 2024-04-03 Not clear
Hiroyuki Awano, Yoshinori Nambu, Chieko Itoh, Akihiro Kida, Tetsushi Yamamoto, Tomoko Lee, Yasuhiro Takeshima, Kandai Nozu, Masafumi Matsu. Longitudinal data of serum creatine kinase levels and motor, pulmonary, and cardiac functions in 337 patients with Duchenne muscular dystrophy. Muscle & nerve. 2024-03-21. PMID:38511270. duchenne muscular dystrophy (dmd) presents with skeletal muscle weakness, followed by cardiorespiratory involvement. 2024-03-21 2024-03-23 Not clear
Kadalraja Raghavan, Thanasekar Sivakumar, Koji Ichiyama, Naoki Yamamoto, Mangaleswaran Balamurugan, Vidyasagar Devaprasad Dedeepiya, Rajappa Senthilkumar, Senthilkumar Preethy, Samuel Jk Abraha. Efficacy of N-163 beta-glucan in beneficially improving biomarkers of relevance to muscle function in patients with muscular dystrophies in a pilot clinical study. Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology. vol 42. issue 4. 2024-02-26. PMID:38406382. muscular dystrophies other than duchenne muscular dystrophy (dmd) are genetic diseases characterized by increasing muscle weakness, loss of ambulation, and ultimately cardiac and respiratory failure. 2024-02-26 2024-02-28 Not clear
Suzanne J Filius, Jaap Harlaar, Lonneke Alberts, Saskia Houwen-van Opstal, Herman van der Kooij, Mariska Mhp Jansse. Design requirements of upper extremity supports for daily use in Duchenne muscular dystrophy with severe muscle weakness. Journal of rehabilitation and assistive technologies engineering. vol 11. 2024-02-13. PMID:38344392. especially for severe muscle weakness (dmd ≥ brooke scale 4), the design of such arm support is challenging. 2024-02-13 2024-02-15 Not clear
Monia Souidi, Jessica Resta, Haikel Dridi, Yvonne Sleiman, Steve Reiken, Karina Formoso, Sarah Colombani, Pascal Amédro, Pierre Meyer, Azzouz Charrabi, Marie Vincenti, Yang Liu, Rajesh Kumar Soni, Frank Lezoualc'h, D V M Stéphane Blot, François Rivier, Olivier Cazorla, Angelo Parini, Andrew R Marks, Jeanne Mialet-Perez, Alain Lacampagne, Albano C Mel. Ryanodine receptor dysfunction causes senescence and fibrosis in Duchenne dilated cardiomyopathy. Journal of cachexia, sarcopenia and muscle. 2024-01-14. PMID:38221511. duchenne muscular dystrophy (dmd) is an x-linked disorder characterized by progressive muscle weakness due to the absence of functional dystrophin. 2024-01-14 2024-01-17 mouse
Andrea Hernández-Sánchez, Lidia Parra-Sánchez, Marisol Montolio, Lola Rueda-Ruzafa, Lucía Ortiz-Comino, María Del Mar Sánchez-Joy. Family Involvement and at-Home Physical Therapy on Duchenne Muscular Dystrophy: A Randomized Controlled Trial. Pediatric neurology. vol 152. 2024-01-07. PMID:38184986. duchenne muscular dystrophy (dmd) is a genetic condition that causes muscle weakness and begins in early childhood. 2024-01-07 2024-01-10 Not clear
Abdelbaset Mohamed Elasbali, Waleed Abu Al-Soud, Mohd Adnan, Hassan H Alhassan, Taj Mohammad, Md Imtaiyaz Hassa. Discovering Promising Biomarkers and Therapeutic Targets for Duchenne Muscular Dystrophy: a Multiomics Meta-Analysis Approach. Molecular neurobiology. 2024-01-02. PMID:38165583. duchenne muscular dystrophy (dmd) is a genetic disorder that causes muscle weakness and degeneration. 2024-01-02 2024-01-10 Not clear
Giorgia Coratti, Marika Pane, Claudia Brogna, Adele D'Amico, Elena Pegoraro, Luca Bello, Valeria A Sansone, Emilio Albamonte, Elisabetta Ferraroli, Elena Stacy Mazzone, Lavinia Fanelli, Sonia Messina, Maria Sframeli, Michela Catteruccia, Gianpaolo Cicala, Anna Capasso, Martina Ricci, Silvia Frosini, Giacomo De Luca, Enrica Rolle, Roberto De Sanctis, Nicola Forcina, Giulia Norcia, Luigia Passamano, Marianna Scutifero, Alice Gardani, Antonella Pini, Giulia Monaco, Maria Grazia D'Angelo, Daniela Leone, Riccardo Zanin, Gian Luca Vita, Chiara Panicucci, Claudio Bruno, Tiziana Mongini, Federica Ricci, Angela Berardinelli, Roberta Battini, Riccardo Masson, Giovanni Baranello, Claudia Dosi, Enrico Bertini, Vincenzo Nigro, Luisa Politano, Eugenio Mercur. Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study. Neuromuscular disorders : NMD. vol 34. 2023-12-29. PMID:38157655. duchenne muscular dystrophy (dmd) is a neuromuscular condition characterized by muscle weakness. 2023-12-29 2024-01-05 Not clear
Victoria Brown, Elizabeth Merikle, Kelly Johnston, Katherine Gooch, Ivana Audhya, Linda Lowe. A qualitative study to understand the Duchenne muscular dystrophy experience from the parent/patient perspective. Journal of patient-reported outcomes. vol 7. issue 1. 2023-12-12. PMID:38085412. duchenne muscular dystrophy (dmd) is a rare, severe, fatal neuromuscular disease characterized by progressive atrophy and muscle weakness, resulting in loss of ambulation, decreased upper body function, and impaired cardiorespiratory function. 2023-12-12 2023-12-17 Not clear
Kuan-Wen Wu, Cheng-Hao Yu, Tse-Hua Huang, Shiuan-Huei Lu, Yu-Lin Tsai, Ting-Ming Wang, Tung-Wu L. Children with Duchenne muscular dystrophy display specific kinematic strategies during obstacle-crossing. Scientific reports. vol 13. issue 1. 2023-10-10. PMID:37816796. duchenne muscular dystrophy (dmd) is a genetic disease characterized by progressive muscle weakness with increased neuromechanical challenge and fall risks, especially during obstructed locomotion. 2023-10-10 2023-10-15 Not clear
Kyriaki Kekou, Maria Svingou, Nikos Vogiatzakis, Evangelia Nitsa, Danai Veltra, Nikolaos M Marinakis, Faidon-Nikolaos Tilemis, Maria Tzetis, Anastasios Mitrakos, Charalambia Tsaroucha, Nicoletta Selenti, Giorgos-Konstantinos Papadimas, Constantinos Papadopoulos, Joanne Traeger-Synodinos, Hanns Lochmuller, Christalena Sofocleou. Retrospective analysis of persistent HyperCKemia with or without muscle weakness in a case series from Greece highlights vast heterogeneous DMD gene variants. Expert review of molecular diagnostics. 2023-09-27. PMID:37754746. retrospective analysis of persistent hyperckemia with or without muscle weakness in a case series from greece highlights vast heterogeneous dmd gene variants. 2023-09-27 2023-10-07 Not clear
Marcelo Dos Santos Voltani Lorena, Estela Kato Dos Santos, Renato Ferretti, G A Nagana Gowda, Guy L Odom, Jeffrey S Chamberlain, Cintia Yuri Matsumur. Biomarkers for Duchenne muscular dystrophy progression: impact of age in the mdx tongue spared muscle. Skeletal muscle. vol 13. issue 1. 2023-09-13. PMID:37705069. dmd results in muscle weakness, loss of ambulation, and death at an early age. 2023-09-13 2023-10-07 mouse
Abdolvahab Ebrahimpour Gorji, Piotr Ostaszewski, Kaja Urbańska, Tomasz Sadkowsk. Does β-Hydroxy-β-Methylbutyrate Have Any Potential to Support the Treatment of Duchenne Muscular Dystrophy in Humans and Animals? Biomedicines. vol 11. issue 8. 2023-08-26. PMID:37626825. duchenne muscular dystrophy (dmd) is an x-linked neuromuscular condition causing progressive muscle weakness and premature death. 2023-08-26 2023-09-07 mouse
Qiliang Xiong, Yuan Liu, Jieyi Mo, Yuxia Chen, Lianghong Zhang, Zhongyan Xia, Chen Yi, Shaofeng Jiang, Nong Xia. Gait asymmetry in children with Duchenne muscular dystrophy: evaluated through kinematic synergies and muscle synergies of lower limbs. Biomedical engineering online. vol 22. issue 1. 2023-07-31. PMID:37525241. in the context of duchenne muscular dystrophy (dmd), a disease characterized by progressive muscle weakness and joint contractures, previous studies have generally assumed symmetrical behavior of the lower limbs during gait. 2023-07-31 2023-08-14 Not clear
Boel De Paep. What Nutraceuticals Can Do for Duchenne Muscular Dystrophy: Lessons Learned from Amino Acid Supplementation in Mouse Models. Biomedicines. vol 11. issue 7. 2023-07-29. PMID:37509672. duchenne muscular dystrophy (dmd), the severest form of muscular dystrophy, is characterized by progressive muscle weakness with fatal outcomes most often before the fourth decade of life. 2023-07-29 2023-08-14 mouse
Tetsushi Yamamoto, Yoshinori Nambu, Ryosuke Bo, Shotaro Morichi, Misato Yanagiya, Masafumi Matsuo, Hiroyuki Awan. Electrocardiographic R wave amplitude in V6 lead as a predictive marker of cardiac dysfunction in Duchenne muscular dystrophy. Journal of cardiology. 2023-07-22. PMID:37481234. duchenne muscular dystrophy (dmd) is an inherited muscular disease characterized by progressive and fatal muscle weakness. 2023-07-22 2023-08-14 Not clear
Jeehyun Lee, Nia O Myrie, Gun-Jae Jeong, Woojin M Han, Young C Jang, Andrés J García, Stanislav Emeliano. In vivo shear wave elasticity imaging for assessment of diaphragm function in muscular dystrophy. Acta biomaterialia. 2023-07-15. PMID:37453552. statement of significance: in dmd patients, muscles experience cycles of regeneration and degeneration that contribute to chronic inflammation and muscle weakness. 2023-07-15 2023-08-14 mouse
Dylan Moutachi, Mégane Lemaitre, Clément Delacroix, Onnik Agbulut, Denis Furling, Arnaud Ferr. Valproic acid reduces muscle susceptibility to contraction-induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical and experimental pharmacology & physiology. 2023-06-29. PMID:37381823. the results of our study indicated that vpa in both murine dmd models reduced the susceptibility to contraction-induced functional loss but increased muscle weakness. 2023-06-29 2023-08-14 mouse
Adelina Balidemaj, Parmis Parsamanesh, Mykhailo Vysochy. Exploring the Dynamics of Caring for a Child With a Terminal Illness of Duchenne Muscular Dystrophy (DMD) and Its Copious Components on the Caregivers. Cureus. vol 15. issue 5. 2023-06-29. PMID:37384074. duchenne muscular dystrophy (dmd) is an inherited disorder that results in increasing muscle degeneration and muscle weakness because of a mutation in the dystrophin protein. 2023-06-29 2023-08-14 human